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Characterising the premonitory stage of
migraine in children: a clinic-based study of
100 patients in a specialist headache
service
N. Karsan1, P. Prabhakar2 and P. J. Goadsby3*
Abstract
Background: The premonitory stage of migraine attacks, when symptomatology outside of pain can manifest
hours to days before the onset of the headache, is well recognised. Such symptoms have been reported in adults
in a number of studies, and have value in predicting an impending headache. These symptoms have not been
extensively studied in children. We aimed to characterise which, if any, of these symptoms are reported in children
seen within a Specialist Headache Service.
Methods: We reviewed clinic letters from the initial consultation of children and adolescents seen within the
Specialist Headache Service at Great Ormond Street Hospital between 1999 and 2015 with migraine in whom we
had prospectively assessed clinical phenotype data. We randomly selected 100 cases with at least one premonitory
symptom recorded in the letter. For these patients, the age at headache onset, presence of family history of
headache, headache diagnosis, presence of episodic syndromes which may be associated with headache,
developmental milestones, gestation at birth, mode of delivery and presence of premonitory symptoms occurring
before or during headache were recorded.
Results: Of the 100 patients selected, 65 % were female. The age range of the patients was 18 months to 15 years
at the time of headache onset. The most common diagnosis was chronic migraine in 58 %, followed by episodic
migraine (29 %), New Daily Persistent Headache with migrainous features (8 %) and hemiplegic migraine (5 %). A
history of infantile colic was noted in 31 % and was the most common childhood episodic syndrome associated
with migraine. The most common premonitory symptoms recorded were fatigue, mood change and neck stiffness.
The commonest number of reported premonitory symptoms was two.
Conclusion: Premonitory symptoms associated with migraine are reported in children as young as 18 months, with
an overall clinical phenotype comparable to adults. Better documentation of this stage will aid parents and
clinicians to better understand the phenotype of attacks, better recognise migraine and thus initiate appropriate
management. Larger studies with a broader base are warranted to understand the extent and implications of these
symptoms for childhood and adolescent migraine.
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Background
Migraine is a complex and disabling pain condition and
affects 4–10 % of school aged children [1, 2]. Migraine is
characterised by recurrent episodes of throbbing head
pain, accompanied by other symptoms including nausea,
vomiting and sensory sensitivities [3]. Additionally, it has
been increasingly well recognised that there are other
significant and disabling symptoms associated with mi-
graine and these can include but are not limited to cogni-
tive change, mood disturbance, neck discomfort and
fatigue [3]. These premonitory symptoms can occur hours
to days before the onset of pain, can occur or persist in
the headache phase, and can indeed persist after the head-
ache has resolved in the postdrome [4]. Various studies
have documented different prevalence’s and phentoypes of
premonitory symptoms in adults [5–11], while less is
understood about this phase in childhood migraine.
The phenotype of migraine differs between adults and
children [12] and this has been attributed to changes in
brain development and myelination [13]. It is also well
recognised that syndromes where pain is not a promin-
ent feature can be precursors to migraine in young chil-
dren; these are classified as ‘episodic syndromes that
may be associated with migraine’ in the ICHD-3 beta
classification of headache disorders [3]. While the epi-
sodic disorders associated with paediatric migraine have
been described over some time [14–17], the difficulties
in obtaining accurate histories from small children, and
a generally lessened interest in premonitory symptoms,
apart from one study in a clinic population [18], have re-
sulted in little data in the literature. Given the increase in
research interest into the premonitory stage of migraine
attacks [5–7, 19], the biology of premonitory-like symp-
tomatology and its contribution to understanding how to
advance migraine therapeutics [20], it is timely to address
these symptoms in childhood migraine. Clarifying the
symptoms may help parents understand what their child
is experiencing, and clinicians relate to, and explain these
symptoms, to families. Here we aimed to examine the
phenotype of premonitory symptoms and premonitory
symptoms occurring during headache for 100 children
seen within a Specialist Headache Service at Great
Ormond Street Hospital for Children in London.
Methods
The study population comprised children and adoles-
cents seen within the Specialist Headache Clinic at Great
Ormond Street Hospital for Children between 1999 and
2015 by authors (PP and PJG). All the patients had a
final diagnosis of migraine or New Daily Persistent
Headache with migrainous features. All the patients had
been seen in the presence of one or more parent or
guardian and where possible the patient histories were
taken from the patient themselves. The very first
consultation in this clinic is where a detailed headache
history is taken and documented. Clinic letters from the
initial headache consultation of children seen were ex-
amined for data acquisition.
Patients (n = 100) for which the clinic letters docu-
mented premonitory symptomatology or premonitory
symptoms occurring during headache were randomly
selected for this study. Typical migraine aura and cra-
nial autonomic symptoms were excluded. The data
were compiled and analysed with the objective of car-
rying out a service evaluation, which in UK practice
does not require Research Ethics Committee review
(http://www.hra-decisiontools.org.uk/research/).
Letter structure
Prospectively, for each patient as part of the routine
clinical assessment, the age of headache onset, headache
diagnosis, presence of episodic syndromes that may be
associated with migraine, age at meeting developmental
milestones of walking and talking, gestation at birth and
mode of delivery, presence of positive family history of
headache and the presence of various premonitory
symptoms were noted. The premonitory symptoms for
which information was collected were all those reported
in any letter.
Data collation
The number of premonitory symptoms reported for
each patient was recorded and the associations with age,
sex and headache diagnosis were analysed. Additionally,
the relationship between episodic syndromes that may
be associated with migraine and particular similar pre-
monitory symptoms was analysed.
Data analysis
Symptoms were tabulated in Excel to provide summary
data. Qualitative differences were examined using the
Chi-squared test. Analyses were performed using IBM
SPSS Statistics 22. P < 0.05 was considered significant.
Results
Data collection was made for patients seen between
1999 and 2015. Patients (n = 100) seen within this
period, who had at least one premonitory symptom re-
corded in the initial consultation letter, were randomly
selected. All of these patients fulfilled ICHD-3 beta cri-
teria for the diagnosis of episodic migraine, chronic mi-
graine, hemiplegic migraine or New Daily Persistent
Headache with migrainous features [3].
Demographics and diagnoses
The mean age of subjects at symptom onset was 8 years
(range 1.5–15 years). The commonest diagnosis was
chronic migraine in 58 %, followed by episodic migraine
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in 29 %, New Daily Persistent Headache with migrain-
ous features in 8 %, sporadic hemiplegic migraine in
4 % and familial hemiplegic migraine in 1 %. Of pa-
tients, 65 % were female and 81 % of all patients had
a positive family history of headache. Most of the co-
hort were born by spontaneous vaginal delivery
(73 %), with the vast majority (80 %) being born
within 37 to 42 weeks’ gestation.
Premonitory features defined
Premonitory symptoms were defined as symptoms
recognised as occurring prior to the onset of pain and
any non-migraine defining features occurring during the
pain. These included: vertigo, neck stiffness, visual blur-
ring and light headedness but excluded photophobia,
phonophobia, osmophobia and nausea. We also ex-
cluded any cranial autonomic features because of their
discrete pathophysiology [21]. Typical migraine aura
symptoms were also excluded. Data were collected for
any symptom within these criteria and twenty-two
symptoms were included in the final dataset (Fig. 1).
Occurrence of premonitory features
Two premonitory symptoms was the commonest num-
ber of premonitory symptoms and was reported by 31 %
of patients (Fig. 2). The mean number of premonitory
symptoms reported was three. Two or more premoni-
tory symptoms were reported by 85 % of patients. The
most common premonitory symptoms reported were fa-
tigue, mood change, yawning, concentration difficulty
and neck stiffness (Fig. 3). There was no significant asso-
ciation with the development of two or more premoni-
tory symptoms and age of symptom onset, gender, or
with headache diagnosis (Table 1).
Association of premonitory symptoms with episodic
symptoms
The commonest reported episodic syndrome that may
be associated with migraine was infantile colic in 31 %.
The presence of colic did not predict the development
of any of the most common premonitory symptoms
(Table 2). Other syndromes were less common (Fig. 4).























Frequency of premonitory symptoms reported 
Fig. 1 Frequency of different premonitory symptoms reported
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Conclusions
Here we report a substantial cohort of patients with mi-
graine premonitory symptoms in order to characterise
their phenotype with respect to those seen in adults.
The data show a comparable set of symptoms docu-
menting their occurrence from the age of 18 months.
While certainly not providing prevalence data broadly,
these symptoms can be used as a basis for studying the
premonitory phase in larger populations of patients.
Moreover, they illustrate the probable fundamental shar-
ing of neurobiological mechanisms between childhood
and adolesecent migraine and the condition in adults.
The mean number of premonitory symptoms was
three and the highest number of premonitory symptoms
recorded was seven. This is comparable to adult studies
[7]. It is possible that children may not report






Commonest premonitory symptoms reported
Fatigue Mood Change Yawning Concentration Change Neck Stiffness
Fig. 3 Number of patients reporting the 5 most common premonitory symptoms
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symptomatology as frequently as adults, and that when
they display symptoms, they are not recognised by par-
ents and carers as being part of the migraine attack [2].
In this cohort, the majority of the children were aged 5
to 12 years, so given this age range there is likely to have
been some variability in the reporting of symptomatol-
ogy. The authors mitigate reporting by probing each pa-
tient with these symptoms; this yields a more complete
analysis although does impart a small time burden dur-
ing the consultation. There was no statistically signifi-
cant association between the reporting of more than two
premonitory symptoms with age, sex and headache diag-
nosis. This is compatible with some other studies, al-
though in the adult based study of Schoonman and
colleagues [7], females more frequently reported pre-
monitory symptoms compared to males. Reporting in-
creased with increasing age in another study [2].
The phenotype of symptoms reported here was com-
parable to adults [5]. Here we did not report less usual
premonitory symptoms, such as face changes reported
by others from retrospective data [18]. Symptoms, such
as hypersalivation and facial pallor, were reported in our
patient cohort but these were less common, and we
would interpret them as possible cranial autonomic
symptoms going forward [22].
Premonitory symptoms, and understanding the basis
and neurobiology of this early phase of a migraine at-
tack, may help develop early acute therapies for mi-
graine. Studies have looked at early treatment of attacks
with domperidone [23–25] and naratriptan [26]; these
studies have been small and the literature is lacking large
randomised placebo-controlled trials in this regard. The
phenotype of some of the commonly reported premoni-
tory symptoms such as yawning, mood change and sleep
disturbance suggest the involvement of brainstem and
hypothalamic structures, including dopaminergic nuclei
and such nuclei have already been implicated as playing
a role in trigeminocervical nociception [22]. Additionally
such structures have been shown in a functional imaging
study to be activated during the premonitory stage in
the absence of pain [20, 27].
Limitations
This study has important limitations in that all the pa-
tients were preselected as having reported premonitory
symptomatology at their first Specialist Headache Clinic
consultation. We sought not to determine the preva-
lence of the symptoms in the entire clinic in contrast to
developing a better understanding of the range of symp-
toms when they were present. The use of clinic letters
limits exploring the symptomatology in patients, al-
though we (PP/PJG) have been interested in the question
of premonitory symptoms over the period of review,
which has standardised to a large extent what is re-
corded. Moreover, we tend to produce clinic letters with
an eye to audit in the future to maintain clinical stan-
dards that lend themselves to this type of retrospective
review. Additionally this patient cohort was clinic based
rather than population based, and generalisability of the
findings is not clear. Chronic migraine was the most
common headache diagnosis in this study likely because
we are a teriary headache centre. This may alter report-
ing of premonitory symptomatology in those children
with frequent, daily or continuous headache. The fre-
quency of migraine headache in this cohort has the
complexity of the overlap between premonitory and
postdromal symptoms. This issue needs further charac-
terisation going forward. We did not determine the pre-
valance of premonitory symptomatology in our clinic
overall nor analyse whether symptoms were able to reli-
ably warn of an impending headache attack. However,
Table 1 Analysis of association between those patients
reporting at least two premonitory symptoms and sex, age of
onset of symptoms and headache diagnosis















Episodic migraine 28 20 0.079








Table 2 Analysis of association between the most common





Odds Ratio P value
Yawning 30 16 0.38
(CI 0.21–0.67)
0.18
Fatigue 62 23 0.73
(CI 0.55–0.97)
0.10
Mood change 55 17 0.96
(CI 0.66–1.4)
0.20
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we have demonstrated a wider range of premonitory
symptoms in the paediatric population across a wide
range of age groups. We have also examined the associ-
ation between the childhood episodic syndomes and the
development of premonitory symptoms.
Recognising the presence of the premonitory phase of
migraine in children allows education of parents and
carers about such symptoms and better recognition of
attacks, particularly in younger children. Future studes
could provide questionnaries or electronic diaries for
these symptoms to be reported by parents and patients
and their relationship to attack onset and their ability to
predict an attack could be assessed. This would be help-
ful in ascertaining the true prevalance of premonitory
symptoms prospectively in a population based sample,
their phenotype and their ability to predict an impending
headache in a paediatric and adolescent population. Un-
derstanding this would allow randomised controlled tri-
als of treatment in the paediatric population, as well as
support further functional imaging and pharmacologci-
cal research against novel therapeutic targets, to aid bet-
ter treatment of this common and disabling condition.
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